31 related articles for article (PubMed ID: 38430974)
21. Diseases of Hereditary Renal Cell Cancers.
Iliopoulos O
Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
[TBL] [Abstract][Full Text] [Related]
22. Hereditary kidney cancer: unique opportunity for disease-based therapy.
Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
[TBL] [Abstract][Full Text] [Related]
23. Shelterin complex and associated factors at human telomeres.
Diotti R; Loayza D
Nucleus; 2011; 2(2):119-35. PubMed ID: 21738835
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
25. No DDRama at chromosome ends: TRF2 takes centre stage.
Feuerhahn S; Chen LY; Luke B; Porro A
Trends Biochem Sci; 2015 May; 40(5):275-85. PubMed ID: 25845889
[TBL] [Abstract][Full Text] [Related]
26. Involvement of multiple loci on chromosome 3 in renal cell cancer development.
van den Berg A; Buys CH
Genes Chromosomes Cancer; 1997 Jun; 19(2):59-76. PubMed ID: 9171996
[TBL] [Abstract][Full Text] [Related]
27. DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection.
Bories C; Lejour T; Adolphe F; Kermasson L; Couvé S; Tanguy L; Luszczewska G; Watzky M; Poillerat V; Garnier P; Groisman R; Ferlicot S; Richard S; Saparbaev M; Revy P; Gad S; Renaud F
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167107. PubMed ID: 38430974
[TBL] [Abstract][Full Text] [Related]
28. SNM1B/Apollo in the DNA damage response and telomere maintenance.
Schmiester M; Demuth I
Oncotarget; 2017 Jul; 8(29):48398-48409. PubMed ID: 28430596
[TBL] [Abstract][Full Text] [Related]
29. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
30. Shelterin-Mediated Telomere Protection.
de Lange T
Annu Rev Genet; 2018 Nov; 52():223-247. PubMed ID: 30208292
[TBL] [Abstract][Full Text] [Related]
31. Fumarate hydratase as a therapeutic target in renal cancer.
Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G
Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
